In the early morning of the 2nd, Beijing time, U. S. stocks closed higher on Friday, but all three major stock indexes fell this week. U.S. president Joe Biden signed a short-term spending bill to avoid a federal shutdown, but did not address the risk of a possible default by the United States.
The Dow closed up 482.54 points, or 1.43%, at 34326.46; the Nasdaq was up 118.12 points, or 0.82%, at 14566.70; and the S & P 500 was up 49.50 points, or 1.15%, at 4357.04.
This week, the Dow is down 1.36%, the S & P 500 is down 2.2%, and the Nasdaq is down 3.2%.
Merck & Co Inc, a constituent stock in the Dow on Friday.It closed 8.4% higher. Merck & Co Inc reported that the oral anti-novel coronavirus drug developed by the company and Ridgeback Biotherapeutics reduced the hospitalization rate and risk of death of COVID-19 patients by 50 per cent. The two companies plan to apply for emergency use authorization (EUA) for the drug.
Driven by Merck & Co Inc's new drug news, travel and other sectors closely related to economic restart generally rose. Royal Caribbean and Las Vegas SandsWait for the stock price to go up.
Southwest Airlines led the rise in the aviation sector, prior to JPMorgan Chase & CoIt upgraded the stock and said most of the group's business confirmed that its shares were worth buying.
Apple Inc, the champion of US stock turnover on Friday.The company closed 0.8% higher, with a turnover of $13.25 billion. Apple Inc released iOS 15.0.1, a small update about a week after the company released the final version of the basic software, focusing on bug fixes and performance improvements.
According to Apple Inc's release notes, iOS 15.0.1 fixed a number of bugs and problems, especially on Apple Inc's new iPhone 13 and iPhone 13 Pro models, including a problem that made it impossible for users to unlock iPhone with Apple Watch.
Moderna Inc, the third largest vaccine developer in COVID-19, closed down 11.4% on a turnover of US $11.62 billion. Affected by Merck & Co Inc's news that his oral anti-COVID-19 drugs can reduce patient hospitalization and mortality by 50 per cent, US vaccine stocks generally fell today.
Similar to Moderna Inc, Novax Pharmaceuticals, another vaccine manufacturer, ranked 13th in US stock turnover today, down 12.4 per cent to $3.02 billion.
Moshadong, the fifth-ranked component of the Dow, closed up 8.4%, the biggest daily gain in five years, with a turnover of $8.37 billion. Merck & Co Inc reported that oral anti-novel coronavirus drugs jointly developed by the company and Ridgeback Biotherapeutics reduced the hospitalization rate and risk of death of patients with mild or moderate COVID-19 by 50 per cent. The two companies plan to apply for emergency use authorization (EUA) for the drug.
The former director of FDA said that Merck & Co Inc's oral COVID-19 medicine may become a specific drug against severe COVID-19 patients who already have symptoms. "it will be a profound change in the rules of the game."
Wall Street analysts pointed out that Merck & Co Inc's clinical data and scale production capacity of the anti-novel coronavirus drug will change the pattern of the pandemic, and the drug may be authorized for emergency use this year.
No. 6 Microsoft CorpIt closed 2.6% higher, with a deal of $8.24 billion. It is reported that the new Microsoft Corp store is ready to be put into use before the release of Windows 11.
Baba ranked 14thIt closed down 2.6% to $2.9 billion.
Five9, the 20th software developer of the cloud contract center, closed 4.7% higher with a transaction of $1.97 billion. ZoomAnd Five9 announced on Thursday that they had decided to abandon a previous merger and acquisition deal worth $14.7 billion. Five9 said the deal did not get enough votes from shareholders. One of the problems for Five9 shareholders may be that Zoom pays a low premium.
After the termination of the transaction, Wells Fargo & CoUpgrade the Five9 rating from synchronized with the big market to outperform the big market, with a target price of $200. Gatong Bei Xiang upgraded its Five9 rating to buy from hold, maintaining its target price of $200.
The following are the 20 most actively traded stocks of the day (by turnover):
(screenshot from Sina Finance APP quotes-US stocks-more data on the left side of the market section) download Sina Finance APP
